China Universal Asset Management Company’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$149K	Buy	8,307 +680	+9%	+$13.6K	0.01%	375
2025 Q4	$179K	Sell	7,627 -482	-6%	-$10.5K	0.01%	354
2025 Q3	$162K	Sell	8,109 -1,152	-12%	-$20.7K	0.01%	346
2025 Q2	$127K	Buy	9,261 +797	+9%	+$7.65K	0.01%	344
2025 Q1	$93.6K	Sell	8,464 -484	-5%	-$5.16K	0.01%	362
2024 Q4	$95.3K	Buy	8,948 +848	+10%	+$10.2K	0.01%	396
2024 Q3	$103K	Buy	8,100 +3,856	+91%	+$57.2K	0.01%	355
2024 Q2	$71.2K	Sell	4,244 -1,659	-28%	-$23.6K	0.01%	326
2024 Q1	$88.5K	Buy	5,903 +2,328	+65%	+$38.1K	0.01%	383
2023 Q4	$53.6K	Buy	3,575 +2,801	+362%	+$36.4K	0.01%	365
2023 Q3	$10.8K	Buy	774 +467	+152%	+$7.5K	﹤0.01%	340
2023 Q2	$3.18K	Sell	307 -6	-2%	-$66	﹤0.01%	405
2023 Q1	$2.89K	Buy	313 +79	+34%	+$727	﹤0.01%	416
2022 Q4	$2.08K	Buy	234 +21	+10%	+$199	﹤0.01%	370
2022 Q3	$2K	Buy	+213	New	+$1.76K	﹤0.01%	361